ETON Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 17:05):

Stats
Šios dienos apimtis	1 434.00
Vidutinė apimtis	61 048.00
Rinkos kapitalizacija	93.89M
EPS	$0 ( 2024-03-14 )
Kita pelno data	( $-0.0200 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-366.00
ATR14	$0.0360 (0.98%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Gruber James R.	Buy	144 677	Stock Option (Right to buy)
2024-02-13	Adams Jennifer Mckie	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Brynjelsen Sean	Buy	438 633	Stock Option (Right to buy)
2024-02-13	Casamento Charles J	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Krempa David	Buy	144 677	Stock Option (Right to buy)

INSIDER POWER
55.37
Last 96 transactions
Buy: 4 266 352 \| Sell: 3 981 653

Tūris Koreliacija

Ilgas: -0.03 (neutral)

Trumpas: -0.98 (very strong negative)

Signal:(63.608) Neutral

Eton Pharmaceuticals Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
POWL	0.923
ALXN	0.914
HPLTU	0.909
LQDA	0.908
FTII	0.906
ARIZ	0.906
HERAU	0.904
BRIV	0.903
CFFE	0.903
FEXD	0.902

10 Labiausiai neigiamai susiję koreliacijos
IRBT	-0.909
SPCX	-0.909
SIDU	-0.9
LGMK	-0.9
ORPH	-0.891
CSSEP	-0.891
NCBS	-0.889
VFF	-0.887
NAKD	-0.886
PIII	-0.883

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Eton Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos

-0.01
( neutral )

-0.03
( neutral )

0.00
( neutral )

-0.11
( neutral )

-0.59
( weak negative )

-0.25
( neutral )

Eton Pharmaceuticals Inc Finansinės ataskaitos

Annual	2022
Pajamos:	$21.25M
Bruto pelnas:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2022
Pajamos:	$21.25M
Bruto pelnas:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2021
Pajamos:	$21.83M
Bruto pelnas:	$19.21M (87.99 %)
EPS:	$-0.0800

FY	2020
Pajamos:	$39 000.00
Bruto pelnas:	$-247 000 (-633.33 %)
EPS:	$-1.330

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.